BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


How America built its high-tech economy. Technology Transfer in the Life-Sciences

Washington, DC. February 17, 2004. An historic study of technologies that are the core of new high-tech companies, Technology Transfer in the Life Sciences, can now be downloaded at www.ThreeArrowsCapital.com. University research departments, federal laboratories, and corporate marketplaces all have pipelines of intriguing new products and services that need an entrepreneur’s vision to be commercialized. When Bill Gates licensed an operating system from Seattle Computer Works and transferred the technology to Microsoft for use with the IBM PC, he illustrated how technology transfer works. Some of the fastest-growing and most successful new high-tech companies have involved taking research or practices in one industry or market and translating it to another. Technologies need new business plans and markets—the talent of entrepreneurs. Technology Transfer in the Life Sciences shows you how and where to take the steps to find technologies and negotiate agreements, forms, and royalties, and to locate capital.

            If a giant corporation develops a new product that proves disappointing, showing annual sales of only $20 million when they need to be $200 million to be kept in the portfolio, chances are the product can be licensed. Many technology transfer agreements require no cash up-front and only that royalties are to be paid from any future sales. Federal research of nearly $30 billion per year in the life sciences alone converts to thousands of technologies that could be the basis of new biotech firms. The structure of DNA was described by the scientists Crick and Watson at Cambridge University in Great Britain, but the birth of the modern biotechnology industry required the different skills and vision of the entrepreneurs of Silicon Valley. Economic development experts, charged with attracting new companies and high-tech employers, have extensive resources in their own backyards that go wanting and need to be used to support new ventures.

            Technology transfer is an immense resource for people seeking to start their own firms, or companies looking to expand their services or products. Technology Transfer in the Life Sciences is free and references sources of technologies, financing, terms, advice, counseling, etc. If you have ever wanted your own company the very best place to start is by examining completed work in nearby university and other labs—developments needing your imagination and business skills. “Given the outpourings of researchers around the world, there’s simply no reason a talented entrepreneur can’t find an intriguing and bankable technology.” Ron Peterson, President, Three Arrows Capital Corp. ###

www.ThreeArrowsCapital.com

Bethesda, MD 20817-6627

Contact: Ronald Peterson,
301 229 6240, cell 240 308 0337
e-mail tarrows@comcast.net      
                                                                 

 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.